Pharmaceutical Contract Manufacturing 2017 Global Market Solution and Services to 2020
WiseGuyReports.Com Publish a New Market Research Report On - “Pharmaceutical Contract Manufacturing 2017 Global Market Solution and Services to 2020”.
PUNE, INDIA, September 15, 2017 /EINPresswire.com/ --The analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.
Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020
For more information or any query mail at sales@wiseguyreports.com
Covered in this report
The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
The report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Catalent
• Lonza
• Pfizer CentreOne
Other prominent vendors
• Abbott
• Aenova
• Amgen
• Apotex
• Aspen
• AstraZeneca
• Aurobindo Pharma
• Baxter
• BERLIN-CHEMIE
• Biocon
• Biogen
• Boehringer Ingelheim
• Celltrion
• Cipla
• Coherus Biosciences
• Daiichi Sankyo
• Dr. Reddy's Laboratories
• Eli Lilly
• Emcure Pharmaceuticals
• Eurofarma Laboratories
• Fareva
• Gedeon Richter
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Hospira
• Impax Laboratories
• Intas Pharmaceuticals
• Janssen Pharmaceuticals
• Lupin
• Merck
• Mitsubishi Tanabe Pharma
• Momenta Pharmaceuticals
• Natco Pharma
• Nexus Pharmaceuticals
• Novo Nordisk
• Orchid Chemicals & Pharmaceuticals
• Par Pharmaceutical
• Parenteral Drugs India
• Patheon
• Piramal
• Roche Holding
• Sanofi
• Synthon
• Teva Pharmaceuticals
• Valeant Pharmaceuticals
• Zentiva
• Zhejiang Huahai Pharmaceutical
• Zydus Cadila
Market driver
• High number of US FDA-approved manufacturing facilities in emerging countries.
• For a full, detailed list, view our report
Market challenge
• Capacity utilization issues and lack of information integration.
• For a full, detailed list, view our report
Market trend
• Huge demand for next-generation biologics.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Ask Query @ https://www.wiseguyreports.com/enquiry/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020
Table Of Contents – Major Key Points
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pharmaceutical manufacturing outsourcing
• Increased regulatory guidelines coupled with healthcare cost containment efforts
• Rapid innovation and reduced product development lifecycle
• High capital investment
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by type of contract manufacturing
• Global API/bulk drug contract manufacturing market
• Global FDF market
PART 08: Geographical segmentation
• Global pharmaceutical contract manufacturing market by geography
• Pharmaceutical contract manufacturing market in Americas
• Pharmaceutical contract manufacturing market in APAC
• Pharmaceutical contract manufacturing market in EMEA
PART 09: Key leading countries
PART 10: Market drivers
• Increased focus on core competence
• High number of US FDA-approved manufacturing facilities in emerging countries
• Shorter time-to-market
PART 11: Impact of drivers
PART 12: Market challenges
• Capacity utilization issues and lack of information integration
• Growing global competition
• Lack of manufacturing standardization
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Consolidation through vertical integration, alliances, and acquisitions
• Huge demand for next-generation biologics
• Value-added services
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor analysis
• Catalent
• Lonza
• Pfizer CentreOne
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
Continue…….
For more information or any query mail at sales@wiseguyreports.com
Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=742758
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
